Impairment of Lysosomal Activity as a Therapeutic Modality Targeting Cancer Stem Cells of Embryonal Rhabdomyosarcoma Cell Line RD

PLoS ONE - United States
doi 10.1371/journal.pone.0110340
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Targeting Midbodies in Ovarian Cancer Stem Cells as a Therapeutic Strategy

2014English

Therapeutic Strategies for Targeting Cancer Stem Cells

Journal of Cancer Metastasis and Treatment
2016English

Therapeutic Targeting of the P53 Pathway in Cancer Stem Cells

Expert Opinion on Therapeutic Targets
Molecular MedicineDrug DiscoveryClinical BiochemistryPharmacology
2012English

Cancer Stem Cells (CSCs) as a Rational Therapeutic Cancer Target, and Screening for CSC-targeting Drugs

Yakugaku Zasshi
PharmacologyPharmaceutical Science
2017English

Targeting the Metabolism of Leukemia Stem Cells as a Novel Therapeutic Strategy

Drugs in Context
Molecular MedicinePharmacology
2013English

Corrigendum: Therapeutic Targeting of a Stem Cell Niche

Nature Biotechnology
Applied MicrobiologyBiotechnologyBiomedical EngineeringMolecular MedicineBioengineering
2008English

Embryonal Rhabdomyosarcoma – A Case Series

Pathology
Forensic MedicinePathology
2020English

MURC/cavin-4 Is Co-Expressed With Caveolin-3 in Rhabdomyosarcoma Tumors and Its Silencing Prevents Myogenic Differentiation in the Human Embryonal RD Cell Line

PLoS ONE
Multidisciplinary
2015English

Therapeutic Targeting of Cancer Stem Cells via Modulation of the Renin-Angiotensin System

Frontiers in Oncology
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy